The increase in BiP level in cytologically normal neurons of AD patients, as well as in AD modeling by Aβ peptides administration and in transgenic in vivo AD models can be considered as manifestations of an adaptive cellular response aimed at restoring protein folding, which can be depleted as the disease progresses. The gene discussed is HSPA5; the disease is Alzheimer disease.